The prevalence and meaning of fatigue in rheumatic disease
- PMID: 8856621
The prevalence and meaning of fatigue in rheumatic disease
Abstract
Objective: To determine the prevalence of fatigue in rheumatic disease; to characterize the strength of associations between demographic and clinical features and fatigue; to identify predictors of fatigue, and to determine the consequence of clinically significant fatigue.
Methods: 1488 consecutive patients with rheumatic disease were assessed with the Clinical Health Assessment Questionnaire, a health status instrument with scales for fatigue, pain, global severity, sleep disturbance, gastrointestinal problems, anxiety, depression, health status, health satisfaction, and work ability. All patients underwent rheumatic disease examinations and laboratory testing.
Results: Fatigue measured by visual analog scale (VAS) was present in 88-98% of patients, but clinically important levels of fatigue (> or = 2.0 on VAS) were present in more than 41% of patients with rheumatoid arthritis (RA) or osteoarthritis (OA) and 76% of those with fibromyalgia (FM). Fatigue was related to almost all demographic and clinical variables, but in multivariate analyses the strongest independent predictors of fatigue were pain, sleep disturbance, depression, tender point count and Health Assessment Questionnaire (HAQ) disability. About 90% of the R2 of the model (all patients = 0.51, RA = 0.49, OA = 0.45, FM = 0.41) was explained by pain, sleep disturbance, and depression. In RA assessed by erythrocyte sedimentation rate, joint count and grip strength, no association of the inflammatory process with fatigue could be found in the multivariate analyses. In measuring health status, fatigue was strongly associated with work dysfunction and general measures of health (VAS of global severity, health status, and health satisfaction).
Conclusion: Fatigue is common across all rheumatic diseases, associates with all measures of distress, and is a predictor of work dysfunction and overall health status. The correlates of fatigue are generally similar across RA, OA and FM. Fatigue assessment adds much to understanding and management of patients and diseases.
Similar articles
-
Measuring the epidemiology of distress: the rheumatology distress index.J Rheumatol. 2000 Aug;27(8):2000-9. J Rheumatol. 2000. PMID: 10955344
-
Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia.J Rheumatol. 2005 Dec;32(12):2421-8. J Rheumatol. 2005. PMID: 16331775
-
Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.J Rheumatol. 2001 Jul;28(7):1712-7. J Rheumatol. 2001. PMID: 11469486
-
Practical issues in psychosocial measures.J Rheumatol. 1997 May;24(5):990-3. J Rheumatol. 1997. PMID: 9150097 Review.
-
The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care.Rheum Dis Clin North Am. 2009 Nov;35(4):787-98, ix. doi: 10.1016/j.rdc.2009.10.011. Rheum Dis Clin North Am. 2009. PMID: 19962623 Review.
Cited by
-
Factors associated with fatigue in hip and/or knee osteoarthritis: a systematic review and best evidence synthesis.Rheumatol Adv Pract. 2021 Feb 26;5(1):rkab013. doi: 10.1093/rap/rkab013. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 33928211 Free PMC article.
-
A Comparative Study on the Pain Threshold Experienced by Fibromyalgia Patients Following Acute SARS-CoV-2 Infection.Life (Basel). 2024 Jul 27;14(8):942. doi: 10.3390/life14080942. Life (Basel). 2024. PMID: 39202684 Free PMC article.
-
Sociodemographic differences in quality of life in rheumatoid arthritis.Pharmacoeconomics. 2006;24(2):109-21. doi: 10.2165/00019053-200624020-00002. Pharmacoeconomics. 2006. PMID: 16460133 Review.
-
Fatigue in fibromyalgia: a conceptual model informed by patient interviews.BMC Musculoskelet Disord. 2010 Sep 20;11:216. doi: 10.1186/1471-2474-11-216. BMC Musculoskelet Disord. 2010. PMID: 20854680 Free PMC article.
-
Patient-reported outcomes and their role in the assessment of rheumatoid arthritis.Pharmacoeconomics. 2004;22(2 Suppl 1):27-38. doi: 10.2165/00019053-200422001-00004. Pharmacoeconomics. 2004. PMID: 15157002 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical